PVG.L Regulatory News (PVG)

14 Mar 2005 17:55

Ark Therapeutics Group PLC14 March 2005 Ark Therapeutics Group plc Director's Share Dealing 14 March 2005: Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company")announces that it was informed today that Professor Seppo Yla-Herttuala, anon-executive director of the Company, sold 200,000 of his ordinary Ark sharesof 1 pence each on 14 March 2005 to meet his annual Finnish wealth taxliabilities. These shares, which represent approximately 0.16% of the Company'sissued share capital, were sold at a price of 102.5 pence per share. Followingthis transaction, Professor Yla-Herttuala will own 4,152,358 ordinary Arkshares, representing 3.29% of the Company's issued share capital. - Ends - This information is provided by RNS The company news service from the London Stock Exchange